Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache: Prospective, Randomized, Controlled, Triple-blinded Trial

NCT04905953 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04905953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04905953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache: Prospective, Randomized, Controlled, Triple-blinded Trial
Lead sponsor
Cairo University
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 1, 2021
Completion date
May 1, 2022
Enrollment
274 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache